కరోనా చికిత్సలో ఆ రెండు ఔషదాలు||Two Drugs: Benefits vs Limitations||
There may be a new ray of hope for COVID-19 victims. A well-known, easily available steroid seems to reduce mortality in critically ill patients, according to a controlled trial.
The steroid, dexamethasone, was given to over 2,100 patients in the RECOVERY trials in the UK, and they were compared to a control group of over 4,300 patients who were not administered the drug. This drug significantly reduces mortality, although it is not useful for milder cases. In the trial, it cut mortality rates by about one-third in patients on ventilators and reduced mortality about 20 per cent for patients on oxygen without ventilators.
The RECOVERY group which ran the trials announced the findings in a press release on Tuesday.
About SocialNewsXYZ
An Indo-American News website. It covers Gossips, Politics, Movies, Technolgy, and Sports News and Photo Galleries and Live Coverage of Events via Youtube. The website is established in 2015 and is owned by AGK FIRE INC.
కరోనా చికిత్సలో ఆ రెండు ఔషదాలు||Two Drugs: Benefits vs Limitations|| There may be a new ray of hope for COVID-19 victims. A well-known, easily available steroid seems to reduce mortality in critically ill patients, according to a controlled trial. The steroid, dexamethasone, was given to over 2,100 patients in the RECOVERY trials in the UK, and they were compared to a control group of over 4,300 patients who were not administered the drug. This drug significantly reduces mortality, although it is not useful for milder cases. In the trial, it cut mortality rates by about one-third in patients on ventilators and reduced mortality about 20 per cent for patients on oxygen without ventilators. The RECOVERY group which ran the trials announced the findings in a press release on Tuesday.